|
|
 |
|
| |
 |
"Translational research" - almost like an incantation, this phrase pops up whenever the discussion comes to research, innovation and the future of our society. But what exactly does it mean? In a truly collaborative approach, the Bernhard Nocht Institute for Tropical Medicine (BNI), a member of the Leibniz Association, the European ScreeningPort, the City of Hamburg, Norgenta and Ascenion have supplied a prime example.more
Inventor Profile
Prof. Michael Bader: Not a job, but a passion
| |
 |
You have been working on cardiovascular hormones for more than 20 years now. What is so exciting about them? First of all, these hormones are incredibly complex. They play important roles in regulating not only the cardiovascular system, but also the central nervous system and immune system. And we still haven’t grasped the full picture. more
Spinning Innovation
Photonion: Online analysis of cigarette smoke, polymers, coffee roasting and more
| |
 |
Photonion is different. Not only because it has a unique, patent-protected technology that impacts countless industrial processes - from coffee roasting and crude oil processing to plastics production - but also because its scientific founder, Professor Ralf Zimmermann, has been collaborating with industry for years. more
Client Portfolio Expanded
In 2009, Ascenion signed partnership agreements with two further institutes from the Leibniz Association: the Leibniz Institute for Agricultural Engineering Potsdam Bornim (ATB) and the German Rheumatism Research Center Berlin (DRFZ). Altogether, Ascenion now supports 15 research institutes in the Helmholtz and Leibniz Associations, together with the Hanover Medical School and the research institute Twincore. Ascenion’s clients now have a total scientific staff of over 4,000 and a cumulative annual budget of about EUR 650million, including third-party funding.more
ATB: First partner from the Leibniz Environmental Science Section
With its unique combination of basic science and engineering expertise, the ATB is a leading innovator in the fields of agricultural production, (bio-) energy and the quality and safety of food and feed.more
DRFZ: New partner of Leibniz Life-Science Section
The DRFZ is internationally renowned for excellence in rheumatology research, with a particular focus on immunology and epidemiology. In Germany alone, rheumatic diseases affect about 1.5 million people - not only the elderly, but also younger people and even children. more
Noteworthy
Owner by default
On 1 October 2009, the German Act on the Simplification and Modernisation of the Patent Law (Gesetz zur Vereinfachung und Modernisierung des Patentrechts) came into force. Most important to German public research organizations and universities is a modification to the Employees’ Invention Law (Arbeitnehmererfindungsgesetz).more
Fostering Networks
BioVaria goes Europe
Though still young, BioVaria has earned its place as one of the few "must join" events for many technology scouts and investors from the international biopharmaceutical sector: primarily, because it is the only life-science event that provides a comprehensive overview of licensing opportunities emanating from publicly funded research.more
For entrepreneurs: Investment and football strategies
Creating viable growth strategies is not easy these days, in particular for life-science entrepreneurs seeking funding for early-stage projects. The upcoming Biotech-NetWorkshop will therefore discuss various corporate development strategies with a particular focus on financing and mergers and acquisitions. more
From blue skies to pots of gold at the end of the rainbow
With this lyrical theme, the Helmholtz Association invited opinion leaders from research, industry and technology transfer for an evening in Brussels to discuss the challenges and opportunities of collaborations between research and industry.more
STS Forum Japan: The future of mankind
Like the World Economic Forum at Davos, the STS forum aims to foster an open dialogue between opinion leaders of various disciplines. The goals are similarly ambitious: more
Crossing borders: 13th Health Industry Forum (HIF) in Beijing
For the first time, Ascenion was not only an invited speaker but also a co-organizer of the International Health Care Forum, one of China’s largest biopharmaceutical conferences. The technology transfer workshop that was jointly held by Ascenion and the BPBC met with strong response from research and industry. more
Latest Technology Offers
- New therapeutic approach for sepsis and infections: in-vivo modulation of natural killer cells via CD27 (TO 02-00250)
- Nucleic acids for efficient conditional inactivation and mutagenesis of eukaryotic genes (TO 02-00097)
- Micro-array reactome: from metabolic networks to gene information (TO 02-00276)
- Novel adjuvant class for use in immunotherapeutics and vaccination (TO 03-00207a)
- Novel peptide drug enhancing immune response in patients suffering from immune suppression and leukopenia (TO 03-00207b)
- Peptides for diagnostic use and for treatment of pulmonary arterial hypertension (TO 03-00255)
- New candidate gene for diagnostic and therapeutic development to combat obesity-associated diabetes (TO 05-00033)
- New highly specific and sensitive marker for adenocarcinomas of the lung: ZP-2 monoclonal antibody (TO 14-00013)
- Casting mould for temporary spacer used in revision surgery (TO 15-00107)
- Treatment of sepsis with MALP-2 (TO 15-00071)
- Treatment for cluster headache disorders (TO 15-00085)
- WT-1 as a prognostic marker for treatment stratification in acute myeloid leukaemia (TO 15-00108)
- Ceramic knee joint prosthesis (TO 15-00110)
- PGFM-detection for pregnancy testing in carnivores (TO 99-00037)
This Information Letter is periodically published by Ascenion GmbH.
Editor: Ascenion GmbH, Herzogstraße 64, 80803 Munich, Germany
Represented by: Dr Christian A. Stein (CEO)
Register Court: Amtsgericht München HRB 118236
VAT Identification Number: DE 812299325
Concept & text: KONOCOM
Layout: Design Direction
Sources of pictures: Ascenion, ATB, BNI, Hamburg, Helmholtz-Association, HIF, HZI, NovaTec, iStockphoto LP, Science Photo Library
Meet us at the forthcoming events:
Biotech-NetWorkshop, 24-26 February 2010, Schloss Ringberg (Tegernsee), Germany
www.ascenion.de
BioVaria, 20 April 2010, Munich, Germany
www.BioVaria.org
BIO International Convention, 3-6 May 2010, Chicago, USA
http://convention.bio.org
ASTP 10th anniversary, 27-28 May 2010, Paris, France
www.astp.net
News in Brief:
Helmholtz Zentrum München renews alliance with Ascenion
Ascenion and the Helmholtz Zentrum München have recently agreed to continue their long-term collaboration.more
HKI becomes member of the Life-Science Foundation
Following four years of collaboration with Ascenion, the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (HKI) joined Ascenion’s parent holding, the Life-Science Foundation for the Promotion of Science and Research.more
DPZ extends license agreement for its antibody against prions
The DPZ anti-prion antibody has been licensed to the French Atomic Energy Commission (CEA, Commissariat à l'énergie atomique) for a further 10 years, to be used as part of an antibody cocktail that is exclusively sublicensed to Bio-Rad.more
NovaTec to commercialize new test for chikungunya fever
A team of researchers from the Bernhard Nocht Institute for Tropical Medicine (BNI), a member of the Leibniz Association, and the German Federal Armed Forces has developed a new ELISA for the diagnosis of chikungunya infections. more
Ascenion acquires shares in BITZ
Ascenion now holds equity in BITZ (Braunschweiger Informatik- und Technologie-Zentrum) gGmbH – a joint venture of the Technical University Braunschweig, the Helmholtz Centre for Infection Research (HZI) and the software and consulting company Lineas.more
Ascenion team news
Marsha Schade joined the Munich team in September 2009 to support the Technology Transfer Competence Centre (KTT), the central service unit for technology transfer and communication within the Federal Program of Medical Genome Research.
Isabell Schwenkert joined the Hanover team in September 2009 as technology scout. Together with her colleague Ralf Cordes, she will work with scientists from the Hanover Medical School (MHH).more
Contact us:
Munich:
T +49 89 318814-0
info(at)ascenion.de
Berlin:
T +49 30 9406 230 -1/-4
berlin(at)ascenion.de
Braunschweig:
T +49 531 6181 2090
braunschweig(at)ascenion.de
Hamburg:
T +49 40 22611 278
hamburg(at)ascenion.de
Hanover:
T +49 511 5328 921
hanover(at)ascenion.de
Neuherberg:
T +49 89 3187 2850
neuherberg@ascenion.de
Ascenion GmbH, www.ascenion.de